首页> 外文OA文献 >Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
【2h】

Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.

机译:通过Ca2 +通道阻滞剂(硝苯地平,地尔硫卓和维拉帕米)的保护,防止氧化的低密度脂蛋白对培养的淋巴样细胞的毒性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Ca2+ channel blockers from 3 different chemical classes (diltiazem, verapamil and nifedipine) were compared in their ability to inhibit low density lipoprotein (LDL) oxidation and to protect cells directly against the cytotoxicity of oxidized LDL. 2. LDL oxidation promoted either by u.v. radiations or by copper ions was inhibited by nifedipine (IC50 of 10 +/- 2 and 4 +/- 0.5 mumol l-1, respectively) whereas diltiazem and verapamil were only poorly active or completely ineffective. As expected, LDL protected from oxidation by nifedipine (nifedipine/oxidized LDL) were much less cytotoxic than (unprotected) oxidized LDL (or than LDL oxidized in the presence of diltiazem or verapamil). The cytotoxic effect correlated well with the lipid peroxidation derivatives measured as the thiobarbituric acid reactive substances (TBARS) content of LDL oxidized in the presence of Ca2+ channel blockers, which suggests that the antioxidant effect of Ca2+ channel blockers protected cells indirectly from the cytotoxic effect of oxidized LDL. 3. Nifedipine also exhibited a direct cytoprotective effect against the cytotoxicity of oxidized LDL as demonstrated by incubating cells in the presence of unprotected oxidized LDL and nifedipine (IC50 of 1 +/- 0.2 mumol l-1), whereas diltiazem and verapamil did not exhibit any significant protective effect. At the concentrations used, the protective effect of nifedipine was not due to inhibition of LDL uptake by Ca2+ channel blockers. 4. The direct protective activity of nifedipine is probably unrelated to its antioxidant properties since it did not inhibit the cellular TBARS evoked by oxidized LDL taken up by the cells, in contrast to vitamin E.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.比较了来自3种不同化学类别(地尔硫卓,维拉帕米和硝苯地平)的Ca2 +通道阻滞剂抑制低密度脂蛋白(LDL)氧化并直接保护细胞免受氧化LDL的细胞毒性的能力。 2.通过紫外线促进LDL氧化硝苯地平可抑制放射线或铜离子的辐射(IC50分别为10 +/- 2和4 +/- 0.5μmoll-1),而地尔硫卓和维拉帕米的活性很差或完全无效。如所预期的,被硝苯地平保护免于氧化的LDL(硝苯地平/氧化的LDL)的细胞毒性比(未保护的)氧化的LDL(或在地尔硫卓或维拉帕米存在下被氧化的LDL)低。细胞毒性作用与脂质过氧化衍生物具有良好的相关性,脂质过氧化衍生物是通过在Ca2 +通道阻滞剂的存在下被氧化的LDL的硫代巴比妥酸反应性物质(TBARS)含量来衡量的,这表明Ca2 +通道阻滞剂的抗氧化作用间接保护细胞免受细胞的毒性作用。氧化的低密度脂蛋白。 3.硝苯地平还对氧化的低密度脂蛋白具有直接的细胞保护作用,如在未保护的氧化低密度脂蛋白和硝苯地平存在下孵育细胞所证实的(IC50为1 +/- 0.2μmoll-1),而地尔硫卓和维拉帕米则没有任何明显的保护作用。在所使用的浓度下,硝苯地平的保护作用并非归因于Ca2 +通道阻滞剂抑制LDL摄取。 4.与维生素E相比,硝苯地平的直接保护活性可能与其抗氧化特性无关,因为它不抑制细胞吸收的氧化LDL诱发的细胞TBARS。(摘要截断为250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号